- Accession Number
Substituted derivatives of hydrazine (formula H2N-NH2).
Drug Drug Description Carbidopa A dopa decarboxylase inhibitor used in combination with levodopa for the symptomatic treatment of idiopathic Parkinson disease and other conditions associated with parkinsonian symptoms. Phenelzine A monoamine oxidase inhibitor used to treat atypical, nonendogenous, or neurotic depression. Levosimendan For short term treatment of acutely decompensated severe chronic heart failure (CHF). Also being investigated for use/treatment in heart disease. Isoniazid An antibiotic used to treat mycobacterial infections; most commonly use in combination with other antimycobacterial agents for the treatment of active or latent tuberculosis. Balsalazide An aminosalicylate used to treat ulcerative colitis. Iproniazid For the treatment of depression (originally intended to treat tuberculosis). Sivifene Investigated for use/treatment in cervical dysplasia/cancer, genital warts, and skin cancer. Aldoxorubicin Investigated for use/treatment in solid tumors. Semapimod Semapimod has been used in trials studying the treatment of Crohn Disease. Simendan Simendan is under investigation in clinical trial NCT00527059 (Renal Effects of Levosimendan in Patients Admitted With Acute Decompensated Heart Failure). Benserazide A medication used to treat Parkinson's disease, parkinsonism, and restless leg syndrome. Meldonium Not Annotated
- Drugs & Drug Targets